GlassScriptPhysician profile
Stacy Boone
NPI 1326021734
$693.01
in general payments reported to CMS, 2019-2025
12 companies · $57.17 in 2025
The $57.17 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $180 · 2023: $111 · 2024: $232 · 2025: $57.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $131.67 | 2021-2025 | |
| Amgen INC. | $121.10 | 2021-2024 | Repatha |
| Medtronic, INC. | $109.14 | 2022-2023 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $95.14 | 2022-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.41 | 2021-2025 | Jardiance |
| Pfizer INC. | $43.42 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.36 | 2021 | |
| Boston Scientific Corporation | $35.78 | 2024 | Watchman Access System |
| Abbott Laboratories | $23.60 | 2022 | |
| Amarin Pharma, INC. | $17.71 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.10 | 2024 | Farxiga |
| Sanofi-Aventis U.S. LLC | $13.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Boone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.